Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage

Cardiovascular Research

Volumn 81, Issue 1, 2009, Pages 28-37

  Urayama, Kyoji ^a   Dedeoglu, Deniz B ^a   Guilini, Célia ^a   Frantz, Stefan ^b   Ertl, Georg ^b   Messaddeq, Nadia ^c   Nebigil, Canan G ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Cardiomyocyte; Fenestration; GPCR; Prokineticin; Transgenic mice; ZO 1

Indexed keywords

ANGIOGENIC FACTOR; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; PROKINETICIN RECEPTOR 2; PROTEIN ZO1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CAPILLARY LEAK SYNDROME; CELL SHAPE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; GENE EXPRESSION; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE CELL; HEART WEIGHT; HYPERTROPHY; MALE; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TIGHT JUNCTION; TRANSGENIC MOUSE; VASCULAR TISSUE;

EID: 57749194568     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn251     Document Type: Article

References (40)

1. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001;412:877-884.
2. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 2001;59:692-698.
3. LeCouter J, Lin R, Tejada M, Frantz G, Peale F, Hillan KJ et al. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 2003;100:2685-2690.
4. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA 2004;101:16813-16818.
5. Dorsch M, Qiu Y, Soler D, Frank N, Duong T, Goodearl A et al. PK1/EG-VEGF induces monocyte differentiation and activation. J Leukoc Biol 2005;78:426-434.
6. Martucci C, Franchi S, Giannini E, Tian H, Melchiorri P, Negri L et al. Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br J Pharmacol 2006;147:225-234.
7. Melchiorri D, Bruno V, Besong G, Ngomba RT, Cuomo L, De Blasi A et al. The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways. Eur J Neurosci 2001;13:1694-1702.
8. Ng KL, Li JD, Cheng MY, Leslie FM, Lee AG, Zhou QY. Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 2005;308:1923-1927.
9. Matsumoto S, Yamazaki C, Masumoto KH, Nagano M, Naito M, Soga Tet al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 2006;103:4140-4145.
10. Negri L, Lattanzi R, Giannini E, Colucci M, Margheriti F, Melchiorri P et al. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J Neurosci 2006;26:6716-6727.
11. Hu WP, Zhang C, Li JD, Luo ZD, Amadesi S, Bunnett N et al. Impaired pain sensation in mice lacking prokineticin 2. Mol Pain 2006;2:35.
12. Li JD, Hu WP, Boehmer L, Cheng MY, Lee AG, Jilek A et al. Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 2006;26:11615-11623.
13. Cheng MY, Bullock CM, Li C, Lee AG, Bermak JC, Belluzzi J et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002;417:405-410.
14. Prosser HM, Bradley A, Chesham JE, Ebling FJ, Hastings MH, Maywood ES. Prokineticin receptor 2 (Prokr2) is essential for the regulation of circadian behavior by the suprachiasmatic nuclei. Proc Natl Acad Sci USA 2007;104:648-653.
15. Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M et al. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun 2002;293:396-402.
16. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 2002;277:19276-19280.
17. Soga T, Matsumoto S, Oda T, Saito T, Hiyama H, Takasaki J et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 2002;1579:173-179.
18. Negri L, Lattanzi R, Giannini E, Melchiorri P. Bv8/Prokineticin proteins and their receptors. Life Sci 2007;81:1103-1116.
19. Ngan ES, Tam PK. Prokineticin-signaling pathway. Int J Biochem Cell Biol 2008;40:1679-1684.
20. Urayama K, Guilini C, Turkeri G, Takir S, Kurose H, Messaddeq N et al. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation. Arterioscler Thromb Vasc Biol 2008;28:841-849.
21. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie TM, Chen J et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat Med 2001;7:1236-1240.
22. Nebigil CG, Maroteaux L. A novel role for serotonin in heart. Trends Cardiovasc Med 2001;11:329-335.
23. Nebigil CG, Launay JM, Hickel P, Tournois C, Maroteaux L. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc Natl Acad Sci USA 2000;97:2591-2596.
24. Nebigil CG, Jaffre F, Messaddeq N, Hickel P, Monassier L, Launay JM et al. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation 2003;107:3223-3229.
25. Nebigil CG, Hickel P, Messaddeq N, Vonesch JL, Douchet MP, Monassier L et al. Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation 2001;103:2973-2979.
26. Nebigil CG, Etienne N, Messaddeq N, Maroteaux L. Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling. FASEB J 2003;17:1373-1375.
27. Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N et al. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 2000;97:9508-9513.
28. Ruppel KM, Willison D, Kataoka H, Wang A, Zheng YW, Cornelissen I et al. Essential role for Galpha13 in endothelial cells during embryonic development. Proc Natl Acad Sci USA 2005;102:8281-8286.
29. Urayama K, Guilini C, Messaddeq N, Hu K, Steenman M, Kurose H et al. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis. FASEB J 2007;21:2980-2993.
30. Frantz S, Brandes RP, Hu K, Rammelt K, Wolf J, Scheuermann H et al. Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX. Basic Res Cardiol 2006;101:127-132.
31. Sano H, Hosokawa K, Kidoya H, Takakura N. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor. Arterioscler Thromb Vasc Biol 2006;26:2673-2680.
32. Tang CM, Insel PA. GPCR expression in the heart; 'new' receptors in myocytes and fibroblasts. Trends Cardiovasc Med 2004;14:94-99.
33. de Gregorio C, Curto L, Recupero A, Grimaldi P, Almoto B, Venturino M et al. Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study. BMC Endocr Disord 2006;6:1-8.
34. Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001;20:2757-2767.
35. Bowman JC, Steinberg SF, Jiang T, Geenen DL, Fishman GI, Buttrick PM. Expression of protein kinase C beta in the heart causes hypertrophy in adultmice and sudden death inneonates. J Clin Invest 1997;100:2189-2195.
36. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res 2000;86:1218-1223.
37. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000;19:6341-6350.
38. Bearer EL, Orci L. Endothelial fenestral diaphragms: a quick-freeze, deep-etch study. J Cell Biol 1985;100:418-428.
39. Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 2004;36:1206-1237.
40. Yan S, Wang X, Chai H, Wang H, Yao Q, Chen C. Secretoneurin increases monolayer permeability in human coronary artery endothelial cells. Surgery 2006;140:243-251.